Allabi, A. Et Al. 2004. Functional impact of CYP2C*5, CYP2C9*6, CYP2C9*8, and CYP2C9*11 in vivo among black Africans. CLINICAL PHARMACOLOGY & THERAPEUTICS , vol.76, no.2 , 113-118.

Allabi, A., Gala, J., Horsmans, Y., Babaoglu, M., Bozkurt, A., Heusterspreute, M., ... Yasar, U.(2004). Functional impact of CYP2C*5, CYP2C9*6, CYP2C9*8, and CYP2C9*11 in vivo among black Africans. CLINICAL PHARMACOLOGY & THERAPEUTICS , vol.76, no.2, 113-118.

Allabi, AC Et Al. "Functional impact of CYP2C*5, CYP2C9*6, CYP2C9*8, and CYP2C9*11 in vivo among black Africans," CLINICAL PHARMACOLOGY & THERAPEUTICS , vol.76, no.2, 113-118, 2004

Allabi, AC Et Al. "Functional impact of CYP2C*5, CYP2C9*6, CYP2C9*8, and CYP2C9*11 in vivo among black Africans." CLINICAL PHARMACOLOGY & THERAPEUTICS , vol.76, no.2, pp.113-118, 2004

Allabi, A. Et Al. (2004) . "Functional impact of CYP2C*5, CYP2C9*6, CYP2C9*8, and CYP2C9*11 in vivo among black Africans." CLINICAL PHARMACOLOGY & THERAPEUTICS , vol.76, no.2, pp.113-118.

@article{article, author={AC Allabi Et Al. }, title={Functional impact of CYP2C*5, CYP2C9*6, CYP2C9*8, and CYP2C9*11 in vivo among black Africans}, journal={CLINICAL PHARMACOLOGY & THERAPEUTICS}, year=2004, pages={113-118} }